4-month Rifapentine-Moxifloxacin-Isoniazid-Pyrazinamide (RPT-M-H-Z) Regimen
Treatment used for 1 condition
Total Trials
50
Total Participants
20K
Avg Effectiveness
88%
Avg Safety Score
55%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.